These results are consistent with human survival data where high NTF2 levels in melanoma correlate with a greater overall survival probability for the first two years, although the trend reverses at later times when other factors may more dominantly influence pathology and disease progression (Fig. S3D). Here, NUTF2 is linked to melanoma.